Enterotoxigenic Bacteroides fragilis

Current Infectious Disease Reports

Volumn 10, Issue 2, 2008, Pages 99-104

  Holton, John ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BACTERIUM LIPOPOLYSACCHARIDE; BETA CATENIN; FRAGILYSIN; UVOMORULIN;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTEROIDES FRAGILIS; CELL ADHESION; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; COLON CANCER; CYTOPATHOGENIC EFFECT; CYTOTOXICITY; DIARRHEA; ELECTROPHYSIOLOGY; ENTERITIS; ENTEROTOXIGENIC BACTEROIDES FRAGILIS; GENE TRANSLOCATION; HUMAN; INFLAMMATION; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; NONHUMAN; PATHOGENICITY ISLAND; PROTEIN DOMAIN; PROTEIN HYDROLYSIS; PROTEIN SECRETION; REVIEW; TIGHT JUNCTION; TRANSEPITHELIAL ELECTRICAL RESISTANCE; TRANSPOSON;

EID: 56349163806     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-008-0018-7     Document Type: Review

References (50)

1. Kuwahara T, Yamashite A, Hirakawa H, et al.: Genomic analysis of Bacteroides fragilis reveals extensive DNA inversions regulating cell surface adaptation. Proc Nat Acad Sci USA 2004, 101:14919-14924.
2. Cerdeño-Tárraga AM, Patrick S, Crossman LC, et al.: Extensive DNA inversions in the B. fragilis genome control variable gene expression. Science 2005, 307:1463-1465.
3. Podglajen I, Breuil J, Casin I, Collatz E: Genotypic identification of two groups within the species Bacteroides fragilis by ribotyping and by analysis of PCR-generated fragment patterns and insertion sequence content. J Bacteriol 1995, 177:5270-5275.
4. Gutacker M, Valsangiacomo C, Piffaretti JC: Identification of two genetic groups in Bacteroides fragilis by multi locus enzyme electrophoresis: distribution of antibiotic resistance (CfiA, CepA) and enterotoxin (btf) encoding genes. Microbiology 2000, 146:1241-1254.
5. Moncrief JC, Duncan AJ, Wright RL et al.: Molecular characterization of the fragilysin pathogenicity islet of enterotoxigenic Bacteroides fragilis. Infect Immun 1998, 66:1735-1739.
6. Franco AA, Cheng RK, Chung GT, et al.: Molecular evolution of the pathogenicity island of enterotoxigenic Bacteroides fragilis strains. J Bacteriol 1999, 181:6623-6633.
7. Buckwold SL, Shoemaker NB, Sears CL, Franco AA: Identification and characterisation of conjugative transposons CTn86 and CTn9343 in Bacteroides fragilis strains. App Environ Microbiol 2007, 73:53-63.
8. Kato N, Liu CX, Kato H, et al.: A new subtype of the metalloprotease toxin gene and the incidence of the three subtypes among Bacteroides fragilis isolates in Japan. FEMS Microbiol Lett 2000, 182:171-176.
9. van Tassell RL, Lyerly DM, Wilkins TD: Purification and characterisation of an enterotoxin from Bacteroides fragilis. Infect Immun 1992, 60:1343-1350.
10. Franco AA, Buckwold SL, Shin JW, et al.: Mutation of the zinc binding metalloprotease motif affects Bacteroides fragilis toxin activity but does not affect propeptide processing. Infect Immun 2005, 73:5273-5277.
11. Sears CL, Buckwald SL, Shin JW, Franco AA: The C-terminal region of Bacteroides fragilis toxin is essential to its biological activity. Infect Immun 2006, 74:5595-5601.
12. Franco AA, Mundy LM, Trucksis M, et al.: Cloning and characterization of the Bacteroides fragilis metalloprotease toxin gene. Infect Immun 1997, 65:1007-1013.
13. Moncrief JS, Obiso RJ, Barroso LA, et al.: The enterotoxin of Bacteroides fragilis is a metalloprotease. Infect Immun 1995, 63:175-181.
14. Weikel CS, Grieco FD, Reuben J, et al.: Human colonic epithelial cells HT29/C1 treated with crude Bacteroides fragilis enterotoxin dramatically alter their morphology. Infect Immun 1992, 60:321-327.
15. Obiso RJ, Lyerly DM, van Tassell RL, Wilkins TD: Proteolytic activity of the Bacteroides fragilis enterotoxin causes fluid secretion and intestinal damage in vivo. Infect Immun 1995, 63:3820-3826.
16. Donelli G, Fabbri A, Fiorentini C: Bacteroides fragilis enterotoxin induces cytoskeletal changes and surface blebbing in HT-29 cells. Infect Immun 1996, 64:113-119.
17. Koshy SS, Montrose MH, Sears CL: Human intestinal epithelial cells swell and demonstrate actin re-arrangement in response to the metalloprotease toxin of Bacteroides fragilis. Infect Immun 1996, 64:5022-5028.
18. Saidi RF, Jaeger K, Montrose MH, et al.: Bacteroides fragilis toxin re-arranges the actin cytoskeleton of HT-29/C1 cells without direct proteolysis of actin or decrease in F-actin. Cell Motil Cytoskeleton 1997, 37:159-165.
19. Obiso RJ, Azghani AO, Wilkins TD: The Bacteroides fragilis toxin fragilysin disrupts the paracellular barrier of epithelial cells. Infect Immun 1977, 65:1431-1439.
20. Chambers FG, Koshy SS, Saidi RF, et al.: Bacteroides fragilis toxin exhibits polar activity on monolayers of human intestinal epithelial cells (T84 cells) in vitro. Infect Immun 1997, 65:3561-3570.
21. Riegler M, Lotz M, Sears CL, et al.: Bacteroides fragilis toxin 2 damages human colonic mucosa in vitro. Gut 1999, 44:504-510.
22. Wu S, Shin J, Zhang G, et al.: The Bacteroides fragilis toxin binds to a specific intestinal epithelial cell receptor. Infect Immun 2006, 74:5382-5390.
23. Wu S, Lim KC, Huang J, et al.: Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc Natl Acad Sci USA 1998, 95:14979-14984.
24. Wu S, Rhee KJ, Zhang M, et al.: Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and gamma-secretase-dependent E-cadherin cleavage. J Cell Science 2007, 120:1944-1952.
25. Wu S, Morin PJ, Maouyo D, Sears CL: Bacteroides fragilis enterotoxin induces c-myc expression and cellular proliferation. Gastroenterology 2003, 124:392-400.
26. Sanfilippo L, Li CK, Seth R, et al.: Bacteroides fragilis enterotoxin induces the expression of IL-8 and transforming growth factor beta (TGF-beta) by human colonic epithelial cells. Clin Exp Immunol 2000, 119:456-463.
27. Kim JM, Oh YK, Kim YJ, Cho YJ: Polarized secretion of CXC chemokines by human intestinal epithelial cells in response to Bacteroides fragilis enterotoxin: NFkappaB plays a major role in the regulation of IL-8 expression. Clin Exp Immunol 2001, 123:421-427.
28. Kim JM, Cho SJ, Oh YK, et al.: Nuclear factor kappa B activation pathway in intestinal epithelial cells is a major regulator of chemokine gene expression and neutrophil migration induced by Bacteroides fragilis enterotoxin. Clin Exp Immunol 2002, 130:59-66.
29. Wu S, Powell J, Mathioudakis N, et al.: Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin 8 through mitogen activated protein kinases and a tyrosine kinase regulated nuclear factor kappa B pathway. Infect Immun 2004, 72:5832-5839.
30. Kim JM, Jung HY, Lee JY, et al.: Mitogen activated protein kinase and activator protein-1 dependent signals are essential for Bacteroides fragilis enterotoxin induced enteritis. Eur J Immunol 2005, 35:2648-2657.
31. Myers LL, Firehammer BD, Shoop DS, Border MM: Bacteroides fragilis: a possible cause of acute diarrhoeal disease in newborn lambs. Infect Immun 1984, 44:241-244.
32. Myers LL, Shoop DS, Stackhouse LL, et al.: Isolation of enterotoxigenic Bacteroides fragilis from humans with diarrhoea. J Clin Micro 1987, 25:2330-2333.
33. Shoop DS, Meyers LL, LeFever JB: Enumeration of enterotoxigenic Bacteroides fragilis in municipal sewage. App Env Microbiol 1990, 56:2243-2244.
34. Sack RB, Meyers LL, Almeido-Hill J, et al.: Enterotoxigenic Bacteroides fragilis: epidemiological studies of its role as a human diarrhoeal pathogen. J Diarrhoeal Dis Res 1992, 10:4-9.
35. Sack RB, Albert MJ, Alam K, et al.: Isolation of enterotoxigenic Bacteroides fragilis from Babgladeshi children with diarrhoea: a case controlled study. J Clin Micro 1994, 32:960-963.
36. San Joaquin VH, Griffis JC, Lee C, Dears CL: Association of Bacteroides fragilis with childhood diarrhoea. Scand J Infect Dis 1995, 27:211-215.
37. Bressane MA, Durigon LE, Avila-Campos MJ: Prevalence of the Bacteroides fragilis group and enterotoxigenic Bacteroides fragilis in immunodeficient children. Anaerobe 2001, 7:277-281.
38. Pantosi A, Menozzi MG, Frate A, et al.: Detection of enterotoxigenic Bacteroides fragilis and its toxin in stool samples from adults and children in Italy. Clin Infect Dis 1997, 24:12-16.
39. Zhang G, Svenungsson B, Karnell A, Weintraub A: Prevalence of enterotoxigenic Bacteroides fragilis in adult patients with diarrhoea and healthy controls. Clin Infect Dis 1999, 29:590-594.
40. Scotto d'Abusco AS, Del Grosso M, Censini S, et al.: The alleles of the bft gene are distributed differently among enterotoxigenic Bacteroides fragilis strains from human sources and can be present in double copies. J Clin Microbiol 2000, 38:607-612.
41. Toprak UN, Rajendram D, Yagci A, et al.: The distribution of the bft alleles among enterotoxigenic Bacteroides fragilis strains from stool specimens and extraintestinal sites. Anaerobe 2006, 12:71-74.
42. Avila-Campos MJ, Liu C, Song Y, et al.: Determination of bft gene subtypes in Bacteroides fragilis clinical isolates. J Clin Microbiol 2007, 45:1336-1338.
43. Cohen SH, Shetab R, Tang-Feldman YJ, et al.: Prevalence of enterotoxigenic Bacteroides fragilis in hospital acquired diarrhoea. Diagn Microbiol Infect Dis 2006, 55:251-254.
44. Toptak NU, Yagci A, Gulluoglu BM, et al.: A possible role of Bacteroides fragilis in the aetiology of colorectal cancer. Clin Microbiol Infect 2006, 12:782-786.
45. Prindiville TP, Sheikh RA, Cohen SH, et al.: Bacteroides fragilis enterotoxin gene sequence in patients with inflammatory bowel disease. Emerg Infect Dis 2000, 6:171-174.
46. Basset C, Holton J, Bazeos A, et al.: Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? Dig Dis Sci 2004, 49:1425-1432.
47. Vines RR, Perdue SS, Moncrief JS, et al.: Fragilysin, the enterotoxin from Bacteroides fragilis enhances the serum antibody response to antigens co-administered by the intranasal route. Vaccine 2000, 19:655-660.
48. Rabizadeh S, Rhee KJ, Wu S, et al.: Enterotoxigenic bacteroides fragilis: a potential instigator of colitis. Inflamm Bowel Dis 2007, 13:1475-1483.
49. Kato N, Kato H, Watanabe K, Ueno K: Association of enterotoxigenic Bacteroides fragilis with bacteraemia. Clin Infect Dis 1996, 23(Suppl 1):S83-S86.
50. Foulon I, Pierard D, Muyldermans G, et al.: Prevalence of fragilysin gene in Bacteroides fragilis isolates from blood and other extraintestinal samples. J Clin Microbiol 2003, 41:4428-4430.